CPG Shake-Up: Tariffs and GLP-1 Drugs Challenge Brands
With ingredient bans, rising tariffs, and the influence of GLP-1 weight-loss drugs, the CPG industry faces a pivotal moment. Forward-thinking brands that embrace strategic supply chain shifts and data-driven consumer insights are most likely to emerge as winners, experts say.